A

APT Medical Inc
SSE:688617

Watchlist Manager
APT Medical Inc
SSE:688617
Watchlist
Price: 237.87 CNY -2.01% Market Closed
Market Cap: ¥33.5B

P/OCF

33.7
Current
28%
Cheaper
vs 3-y average of 46.7

Price to Operating Cash Flow (P/OCF) ratio compares a company`s market value to the cash it generates from its core operations.

P/OCF
33.7
=
Market Cap
¥35B
/
Operating Cash Flow
¥993.3m

Price to Operating Cash Flow (P/OCF) ratio compares a company`s market value to the cash it generates from its core operations.

P/OCF
33.7
=
Market Cap
¥35B
/
Operating Cash Flow
¥993.3m

Valuation Scenarios

APT Medical Inc is trading below its 3-year average

If P/OCF returns to its 3-Year Average (46.7), the stock would be worth ¥329.73 (39% upside from current price).

Statistics
Positive Scenarios
2/4
Maximum Downside
-46%
Maximum Upside
+42%
Average Downside
2%
Scenario P/OCF Value Implied Price Upside/Downside
Current Multiple 33.7 ¥237.87
0%
3-Year Average 46.7 ¥329.73
+39%
5-Year Average 47.8 ¥337.3
+42%
Industry Average 19.5 ¥137.78
-42%
Country Average 18.3 ¥128.95
-46%

Forward P/OCF
Today’s price vs future operating cash flow

Not enough data available to calculate forward P/OCF

Peer Comparison

All Multiples
P/OCF
P/E
All Countries
Close
Market Cap P/OCF P/E
CN
APT Medical Inc
SSE:688617
33.5B CNY 33.7 38.6
US
Intuitive Surgical Inc
NASDAQ:ISRG
162.5B USD 53.6 56.9
US
Abbott Laboratories
NYSE:ABT
157.7B USD 16.5 25.1
US
Stryker Corp
NYSE:SYK
120.5B USD 23.9 37.1
IE
Medtronic PLC
NYSE:MDT
103.9B USD 14.3 22.5
US
Boston Scientific Corp
NYSE:BSX
85.4B USD 18.8 24
US
Edwards Lifesciences Corp
NYSE:EW
48.5B USD 30.4 44.2
DE
Siemens Healthineers AG
XETRA:SHL
39.3B EUR 13 18.6
US
IDEXX Laboratories Inc
NASDAQ:IDXX
44.7B USD 37.8 42.2
US
Becton Dickinson and Co
NYSE:BDX
42.4B USD 12.5 24.2
US
Resmed Inc
NYSE:RMD
31.1B USD 16.3 21

Market Distribution

In line with most companies in China
Percentile
68th
Based on 6 232 companies
68th percentile
33.7
Low
0.2 — 9.8
Typical Range
9.8 — 36.5
High
36.5 —
Distribution Statistics
China
Min 0.2
30th Percentile 9.8
Median 18.3
70th Percentile 36.5
Max 266 666.7

APT Medical Inc
Glance View

Market Cap
33.5B CNY
Industry
Health Care

APT Medical Inc. is a company embedded in the intricate world of medical devices, specializing in the development, production, and distribution of cardiovascular and peripheral vascular medical products. The company’s foundation rests on its ability to innovate and provide solutions that address the complex challenges faced by healthcare professionals in the treatment of heart and vascular diseases. APT Medical strategically focuses on minimally invasive technologies, which are increasingly preferred for their reduced patient recovery times and overall improvement in procedural success rates. By keeping its pulse on the evolving demands within the healthcare sector, APT Medical efficiently aligns its research and development initiatives to meet the global standards and expectations. Revenue streams for APT Medical Inc. flow primarily from its broad portfolio of interventional medical devices, such as guidewires, balloon catheters, and vascular closure devices. The intricacy of their manufacturing processes, coupled with stringent regulatory requirements, ensures that their offerings are both high in quality and competitively priced. Through a network of strategic partnerships, distribution channels, and a robust export framework, the company extends its reach across several international markets. By maintaining a keen focus on customer service and post-market support, APT Medical not only thrives on initial sales but also secures a steady stream of revenue from recurring purchases and long-term partnerships with healthcare institutions globally.

Intrinsic Value
246.54 CNY
Undervaluation 4%
Intrinsic Value
Price ¥237.87
A
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett